Fig. 3From: Serum microRNAs as novel biomarkers for early prediction of disease severity in patients with acute pancreatitisROC curve analysis for the ability of serum biomarkers to predict the development of SAP (n = 38) from HCs (n = 52), MAP (n = 45) and MSAP (n = 42). MiR-19a (a), miR-143 (b), miR-374-5p (c), as well as APACHE II (e) and Ranson scores (f), could identify SAP patients from HC, MAP, especially MSAP, whereas CRP (d), could not differentiate SAP from MSAP (p = 0.056). The AUCs for 3 selected miRNAs were comparable to the APACHE II and Ranson scoresBack to article page